Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...
New Tools for New Creatives. Get all the latest creative apps plus seamless ways to share and collaborate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback